PATENT CLAIM ANALYSIS

Application Number: 16004921
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
A binding moiety (B) for Carbonic Anhydrase IX (CAIX), the binding moiety comprising: The binding moiety is univalent, bivalent, or multivalent. A targeted therapeutic agent may comprise the binding moiety. The invention also includes a method for treating a disease expressing elevated levels of CAIX by administering the targeted therapeutic agent.

Claim (Index 5):
The targeted therapeutic agent of  claim 1 , wherein said binding moiety is a multivalent binding moiety having two or more ligands for binding to CAIX.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.55
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15431310', '15124058', '14722307', '15477721', '13897911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7819361549891937
- 35 USC 102 Novelty (BERT): 0.5754085955621223
- Combined Prediction Score: 0.7612833990464866
- Mean Citation Score: 324.67310600000013
- Max Citation Score: 537.9128400000002
- Similarity Product: 351.060029291382

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test